Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

EVP Research & Development

EVP, Chief Commercial Officer

President & CEO

VP, Chief Accounting Officer

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a skeletal muscle troponin activator, which is in Phase III clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; and aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activat...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-25	Premium	sold	Premium	Premium	Premium	-
2024-04-12	Premium	gifted	Premium	Premium	Premium	EVP Research & Development
2024-04-09	Premium	acquired	Premium	Premium	Premium	EVP Research & Development
2024-04-09	Premium	sold	Premium	Premium	Premium	EVP Research & Development
2024-03-14	Premium	acquired	Premium	Premium	Premium	EVP, Chief Commercial Officer
2024-03-14	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-03-14	Premium	acquired	Premium	Premium	Premium	EVP Research & Development
2024-03-14	Premium	acquired	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-03-06	Premium	sold (taxes)	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-03-06	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2024-03-06	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Commercial Officer
2024-03-06	Premium	sold (taxes)	Premium	Premium	Premium	EVP Research & Development
2024-03-05	Premium	sold	Premium	Premium	Premium	EVP Research & Development
2024-03-05	Premium	acquired	Premium	Premium	Premium	EVP Research & Development
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	VP, Chief Accounting Officer
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Chief Commercial Officer
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	EVP Research & Development
2024-02-14	Premium	acquired	Premium	Premium	Premium	-
2024-02-14	Premium	sold	Premium	Premium	Premium	-
2024-02-13	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-02-13	Premium	sold	Premium	Premium	Premium	President & CEO
2024-02-06	Premium	sold	Premium	Premium	Premium	EVP Research & Development
2024-02-06	Premium	acquired	Premium	Premium	Premium	EVP Research & Development
2024-01-31	Premium	acquired	Premium	Premium	Premium	President & CEO

CYTK - Cytokinetics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for CYTK